Amgen Stock Analysis - $AMGN -is AMGN Stock a Good Buy Today?

TL;DR

Analyzing Amgen's business, revenue trends, and unique valuation method to determine stock fair value.

Transcript

hi i'm jimmy in this video we're looking at amgen stock ticker symbol amgn this video is part of our dial 30 series where we're analyzing all 30 companies in the dow jones industrial average to see which ones could be a good buy today which ones are reasonably priced since we know a lot of the stock market is overvalued right now i'll leave a link ... Read More

Key Insights

• 🤩 Amgen's revenue heavily relies on a few key products, highlighting the importance of continuous product development.
• 😷 Recent drug approvals, like Lumicros for specific conditions, demonstrate Amgen's commitment to addressing unmet medical needs.
• 🧚 Unique valuation methods, such as discounted cash flow analysis, offer insights into a company's fair stock value based on individual product projections.
• 🥺 Market reactions to news about competitor drugs can lead to stock price volatility, emphasizing the importance of thorough valuation approaches.
• 🆘 Understanding individual products' contributions to overall value helps investors make informed decisions on stock pricing.
• 🖐️ Biosimilars and pipeline drugs play a significant role in Amgen's projected revenue and stock valuation.
• 🪐 Monitoring corporate expenses and net debt is essential to accurately assess a company's true value.

Questions & Answers

Q: What is Amgen's primary focus as a biopharmaceutical company?

Amgen specializes in researching and creating medicines, with a significant portion of revenue coming from a few key products in their portfolio.

Q: Why is continuous development of new products important for companies like Amgen?

Developing new products is crucial for sustained success as it takes time for products to get approved, and not all are successful, necessitating a continuous pipeline of offerings.

Q: How does the recent approval of Amgen's cancer drug impact their revenue projections?

The approval of drugs like Lumicros for specific patient populations with genetic mutations can significantly boost Amgen's revenue projections, as seen with estimates exceeding a billion dollars annually.

Q: How does the discounted cash flow valuation method help determine Amgen's fair stock value?

By projecting revenue for each product line up to 2030, discounting them back to present value, and summing them up, the method provides a holistic view of Amgen's fair stock value.

Summary & Key Takeaways

• Amgen is a biopharmaceutical company focusing on researching and creating medicines, with revenue predominantly from a few key products.

• Continuous development and acquisition of new products are crucial for Amgen's success, as seen with recent drug approvals.

• Detailed discounted cash flow valuation method used to determine Amgen's fair stock value based on individual product projections.